- Home
- MYO vs EPRX Comparison
MYO vs EPRX Comparison
Compare MYO & EPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYO
- EPRX
- Stock Information
- Founded
- MYO 2004
- EPRX 2011
- Country
- MYO United States
- EPRX Canada
- Employees
- MYO N/A
- EPRX N/A
- Industry
- MYO Industrial Specialties
- EPRX
- Sector
- MYO Health Care
- EPRX
- Exchange
- MYO Nasdaq
- EPRX NYSE
- Market Cap
- MYO 113.3M
- EPRX 90.8M
- IPO Year
- MYO 2017
- EPRX N/A
- Fundamental
- Price
- MYO $3.73
- EPRX $2.54
- Analyst Decision
- MYO Strong Buy
- EPRX
- Analyst Count
- MYO 4
- EPRX 0
- Target Price
- MYO $7.63
- EPRX N/A
- AVG Volume (30 Days)
- MYO 211.6K
- EPRX 4.3K
- Earning Date
- MYO 08-06-2024
- EPRX 01-01-0001
- Dividend Yield
- MYO N/A
- EPRX N/A
- EPS Growth
- MYO N/A
- EPRX N/A
- EPS
- MYO N/A
- EPRX N/A
- Revenue
- MYO $21,111,062.00
- EPRX N/A
- Revenue This Year
- MYO $53.19
- EPRX N/A
- Revenue Next Year
- MYO $39.01
- EPRX N/A
- P/E Ratio
- MYO N/A
- EPRX N/A
- Revenue Growth
- MYO 21.22
- EPRX N/A
- 52 Week Low
- MYO $0.84
- EPRX $2.39
- 52 Week High
- MYO $5.64
- EPRX $3.50
- Technical
- Relative Strength Index (RSI)
- MYO 43.24
- EPRX N/A
- Support Level
- MYO $3.70
- EPRX N/A
- Resistance Level
- MYO $4.50
- EPRX N/A
- Average True Range (ATR)
- MYO 0.27
- EPRX 0.00
- MACD
- MYO -0.01
- EPRX 0.00
- Stochastic Oscillator
- MYO 14.44
- EPRX 0.00
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).
About EPRX EUPRAXIA PHARMACEUTICALS INC
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.